← SynDRA
SRA-737
SynDRA canonical compound SYN0039311 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CHEK1 |
|---|
| Mechanism of action | kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- CHEK1 INHIBITOR
- CHEK2 INHIBITOR
- kinase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CLK2
- FLT3
- KCNH2
- RPS6KA3
- RPS6KA1
- KDR
- PRKD1
- NUAK1
- PHKG1
- MAPK15
- BRSK1
- MARK3
- PDK1
- PAK6
- PAK5
- PAK4
- PIM1
- PAK2
- OSR1
- PIM2
- OGG1
- ABL1
- NTHL1
- NTRK1
- MKNK2
- MARK2
- MARK4
- MBD4
- MELK
- MINK1
- MKNK1
- MUTYH
- PKD1
- MYLK
- NEIL1
- NEIL2
- NEK2
- NEK6
- NR2C2
- PIM3
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CCNB1
- CDK1
- PRKAA1
- PRKAB1
- PRKAG1
Cross-references
Synonyms
- Sra737
- CCT-245737
- CCT245737
- CCT245737 FREE BASE
- PNT-737
- PNT737
- SRA737
- QB6LNL4NF6
- RefChem:932145
- Chk1 Inhibitor SRA737
- Chk1 Inhibitor CCT245737
- Checkpoint Kinase 1 Inhibitor CCT245737
- SRA-737 [WHO-SDG]
- MFCD30489721
- UNII-QB6LNL4NF6
- GTPL9187
- orb1300093
- SCHEMBL15392098
- SCHEMBL29374363
- SRA 737 [WHO-DD]
- US9663503, Compound 1
- C16H16F3N7O
- YBYYWUUUGCNAHQ-LLVKDONJSA-N
- BDBM328993
- GLXC-10700
- SRA737; PNT-737
- EX-A1607
- PJC38918
- NSC793726
- AKOS030629815
- CCG-268393
- compound 4 [PMID: 27167172]
- CS-5863
- NSC-793726
- SRA737(CCT245737)?
- AC-36122
- BS-15458
- HY-18958
- T7080
Look up SRA-737 in the interactive SynDRA portal →